Individualization of antihypertensive drug therapy.
D001810:Blood Volume; D002302:Cardiac Output; D004232:Diuretics / Q000627:therapeutic use; D006145:Guanethidine / Q000008:administration & dosage / Q000378:metabolism* / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000008:administration & dosage / Q000378:metabolism* / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy* / Q000201:enzymology / Q000209:etiology; D007408:Intestinal Absorption; D008750:Methyldopa / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D012110:Reserpine / Q000627:therapeutic use; D013564:Sympathetic Nervous System / Q000187:drug effects; D014655:Vascular Resistance; D014665:Vasodilator Agents / Q000627:therapeutic use
D004232:Diuretics; D014665:Vasodilator Agents; D006830:Hydralazine; D008750:Methyldopa; D012110:Reserpine; D011433:Propranolol; D006145:Guanethidine